Back to search

Virginia Commonwealth University

Synthesis and Evaluation of Anibamine and Its Analogs as Novel Anti-Prostate Cancer Agents

Abstract

dc:description.abstract

The chemokine receptor CCR5 has been implicated in the pathogenesis of prostate cancer. A novel natural product, anibamine, was isolated and found to be a micromolar inhibitor of the receptor. Anibamine was used as a new anti-prostate cancer lead compound. To discover the pharmacophore, analogs of anibamine were designed using the “deconstruction-reconstruction-elaboration” approach and synthesized. The establishment of a stereoselective route to only one isomer was explored, to increase yield and eliminate elaborate purification procedures. Analogs were found to have anti-prostate cancer activity at levels higher than the parent compound. The molecular modeling studies of the deconstructed analogs indicate that due to the psuedo-symmetry of the parent compound, the binding conformation of the deconstructed analogs may not be very different from each other. All this information together may help identify a next generation lead compound for anti-prostate cancer treatment.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
Thesis
Discipline thesis:degree_discipline
Medicinal Chemistry

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Haney, Kendra
Contributors dc:contributor
  • Yan Zhang

Subjects

dc:subject × 6

Rights

dc:rights
Statement dc:rights
  • © The Author

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Virginia Commonwealth University
Base URL
scholarscompass.vcu.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Haney, Kendra. Synthesis and Evaluation of Anibamine and Its Analogs as Novel Anti-Prostate Cancer Agents. Thesis thesis, https://doi.org/10.25772/1BWH-BV49